Balasa Dinverno & Foltz’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$1.43M Sell
20,065
-2,046
-9% -$145K 0.09% 93
2022
Q2
$1.7M Buy
22,111
+3,698
+20% +$285K 0.11% 78
2022
Q1
$1.35M Buy
18,413
+2,041
+12% +$149K 0.09% 99
2021
Q4
$1.02M Sell
16,372
-7,145
-30% -$446K 0.07% 126
2021
Q3
$1.39M Buy
23,517
+168
+0.7% +$9.94K 0.1% 97
2021
Q2
$1.56M Sell
23,349
-324
-1% -$21.6K 0.11% 88
2021
Q1
$1.49M Sell
23,673
-1,037
-4% -$65.4K 0.12% 87
2020
Q4
$1.53M Buy
24,710
+920
+4% +$57.1K 0.13% 79
2020
Q3
$1.43M Buy
23,790
+978
+4% +$59K 0.14% 69
2020
Q2
$1.34M Sell
22,812
-2,692
-11% -$158K 0.15% 64
2020
Q1
$1.42M Buy
25,504
+935
+4% +$52.1K 0.18% 53
2019
Q4
$1.58M Buy
24,569
+7,265
+42% +$466K 0.17% 60
2019
Q3
$877K Sell
17,304
-384
-2% -$19.5K 0.1% 100
2019
Q2
$802K Sell
17,688
-840
-5% -$38.1K 0.09% 102
2019
Q1
$884K Sell
18,528
-939
-5% -$44.8K 0.11% 85
2018
Q4
$1.01M Sell
19,467
-4,178
-18% -$217K 0.13% 75
2018
Q3
$1.47M Sell
23,645
-257
-1% -$16K 0.17% 52
2018
Q2
$1.32M Sell
23,902
-1,325
-5% -$73.3K 0.19% 50
2018
Q1
$1.6M Sell
25,227
-310
-1% -$19.6K 0.24% 38
2017
Q4
$1.57M Sell
25,537
-333
-1% -$20.4K 0.23% 43
2017
Q3
$1.65M Sell
25,870
-1,173
-4% -$74.8K 0.26% 39
2017
Q2
$1.51M Buy
27,043
+5,756
+27% +$321K 0.25% 35
2017
Q1
$1.16M Buy
21,287
+9,665
+83% +$526K 0.2% 42
2016
Q4
$679K Buy
11,622
+82
+0.7% +$4.79K 0.12% 77
2016
Q3
$622K Buy
11,540
+110
+1% +$5.93K 0.11% 76
2016
Q2
$841K Buy
11,430
+1,428
+14% +$105K 0.15% 56
2016
Q1
$639K Buy
10,002
+50
+0.5% +$3.19K 0.11% 66
2015
Q4
$685K Buy
9,952
+217
+2% +$14.9K 0.12% 64
2015
Q3
$576K Sell
9,735
-8
-0.1% -$473 0.1% 77
2015
Q2
$648K Sell
9,743
-1,394
-13% -$92.7K 0.11% 66
2015
Q1
$718K Sell
11,137
-1,080
-9% -$69.6K 0.1% 62
2014
Q4
$721K Sell
12,217
-80
-0.7% -$4.72K 0.1% 64
2014
Q3
$629K Buy
12,297
+1,250
+11% +$63.9K 0.1% 67
2014
Q2
$536K Sell
11,047
-310
-3% -$15K 0.06% 74
2014
Q1
$590K Buy
11,357
+1,562
+16% +$81.1K 0.07% 65
2013
Q4
$521K Buy
9,795
+138
+1% +$7.34K 0.07% 66
2013
Q3
$447K Buy
9,657
+351
+4% +$16.2K 0.07% 64
2013
Q2
$416K Buy
+9,306
New +$416K 0.07% 63